Wharton’s Jelly

As I mentioned last week, I’m currently taking a hybrid classroom/clinical duties course centered around immunology and the immunocompromised patient. I’ve just finished a week on the stem cell transplant unit, where most patients have received a bone marrow transplant to treat leukemia. In general, these patients come to the hospital for one of three reasons:

  • To get their bone marrow transplant;
  • Their leukemia relapsed;
  • They developed an awful complication called graft-vs-host disease.

Continue reading